MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 11, 2007; DOI: 10.1124/mol.107.039602


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039602v1
72/6/1476    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, X.-K.
Right arrow Articles by Hamel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, X.-K.
Right arrow Articles by Hamel, E.


Received for publication July 5, 2007.
Revised September 5, 2007.
Accepted for publication September 10, 2007.

Transforming growth factor-{beta}1 impairs endothelin-1-mediated contraction of brain vessels via induction of mitogen-activated protein kinase phosphatase-1 and inhibition of p38 MAP kinase

Xin-Kang Tong 1 Edith Hamel 1*

1 Montreal Neurological Institute

* Address correspondence to: E-mail: edith.hamel{at}mcgill.ca

Abstract

Brain levels of transforming growth factor-{beta}1 (TGF-{beta}1) are increased in Alzheimer's disease and have been implicated in the associated cerebrovascular pathology. We recently reported that transgenic mice that overexpress TGF-{beta}1 (TGF+mice) display, with aging, selectively reduced endothelin-1 (ET-1)-mediated contractions. As ET-1 is a key regulator of cerebrovascular tone and homeostasis, we investigated how increased levels of TGF-{beta}1 could selectively alter this contractile response. We found that ETA receptors, via activation of p38 MAP kinase, mediate the ET-1-induced contractions in mouse cerebral arteries, a response significantly decreased in aged TGF+ mice (-39%, p<0.01) despite unaltered ETA receptor levels or affinity. In cerebrovascular smooth muscle cell cultures, chronic TGF-{beta}1 significantly decreased (>50%, p<0.05) the ET-1-induced activation of the p38 MAPK/heat shock protein 27 (HSP27) signaling pathway. This occurred with no effect upstream to p38 MAP kinase, but with the concomitant induction of mitogen-activated protein kinase phosphatase-1 (MKP-1) expression. Inhibition of MKP-1 expression with Ro-31-8220 or suppression of MKP-1 expression by short interfering RNA restored the ET-1-mediated p38 MAP kinase response. These results disclose a new role for chronic TGF-{beta}1 in modulating cerebrovascular tone by dampening ET-1-mediated activation of the p38 MAPK/HSP27 signaling pathway. Such changes in ET-1-mediated signaling may help maintain vascular wall homeostasis by compensating for the diminished dilatory function induced by TGF-{beta}1 and amyloid-{beta}, two molecules which brain levels are increased in patients with Alzheimer's disease.


Key words: Endothelin, P38 MAP Kinase, Func. analysis receptor/ion channel mutants





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics